Australasian randomised clinical trial comparing laparoscopic and open surgical treatment of colon cancer: Follow-up.

比较腹腔镜手术和开腹手术治疗结肠癌的澳大利亚随机临床试验:随访。

基本信息

  • 批准号:
    nhmrc : 349381
  • 负责人:
  • 金额:
    $ 15.54万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2005
  • 资助国家:
    澳大利亚
  • 起止时间:
    2005-01-01 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

Colon cancer is one of the most common solid tumours in western society. The usual initial treatment is excision of the cancer by an operation done through a cut down the midline of the abdominal wall. Over the past 15 years, minimally invasive technology has changed the approach to many surgical operations. A good example of this is an operation to remove the gall bladder. This is now routinely done using a laparoscope (telescope) which is introduced at the umbilicus. An image on a video screen of the gall bladder is then used to guide instruments to remove the gall bladder without making a large incision in the abdominal wall. This is called a laparoscopic cholecystectomy. The safety of a laparoscopic assisted approach in the removal of colon cancer is yet to be determined. This study will compare the long term and short term outcomes of people who have colon cancers removed whether by laparotomy ( a cut in the midline of the abdominal wall) or by a laparoscopic assisted approach (telescope).
结肠癌是西方社会最常见的实体瘤之一。通常的初始治疗是通过沿腹壁中线切开的手术切除癌症。在过去的15年里,微创技术已经改变了许多外科手术的方法。一个很好的例子是切除胆囊的手术。这是现在例行使用腹腔镜(望远镜),这是引入在脐。然后,使用视频屏幕上的胆囊图像来引导器械在不对腹壁进行大切口的情况下切除胆囊。这就是所谓的腹腔镜胆囊切除术。腹腔镜辅助方法切除结肠癌的安全性尚未确定。这项研究将比较结肠癌患者的长期和短期结果,无论是通过剖腹手术(在腹壁中线切开)还是腹腔镜辅助方法(望远镜)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A/Pr Andrew Stevenson其他文献

A/Pr Andrew Stevenson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A/Pr Andrew Stevenson', 18)}}的其他基金

A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial. A phase III prospective randomised trial comparing laparoscopic-assisted resection versus open resection for rectal cancer
A La CaRT:澳大利亚腹腔镜直肠癌试验。
  • 批准号:
    nhmrc : 1078113
  • 财政年份:
    2015
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Project Grants
A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial. A phase III prospective randomised trial comparing laparoscopic-assisted resection versus open resection for rectal cancer
A La CaRT:澳大利亚腹腔镜直肠癌试验。
  • 批准号:
    nhmrc : GNT1078113
  • 财政年份:
    2015
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Project Grants
A La CaRT: Australasian phase III randomised trial comparing laparoscopic-assisted versus open resection for rectal cancer
A La CaRT:澳大利亚 III 期随机试验,比较腹腔镜辅助与开腹直肠癌切除术
  • 批准号:
    nhmrc : 1009973
  • 财政年份:
    2011
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Project Grants
AUSTRALASIAN MULTICENTRED PROSPECTIVE RANDOMISED STUDY OF LAPAROSCOPIC VS CONVENTIONAL SURGICAL TREATMENT OF COLON CA
澳大利亚腹腔镜与传统结肠癌手术治疗的多中心前瞻性随机研究
  • 批准号:
    nhmrc : 207815
  • 财政年份:
    2002
  • 资助金额:
    $ 15.54万
  • 项目类别:
    NHMRC Project Grants

相似海外基金

Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
  • 批准号:
    490098
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Operating Grants
Consent to access and use routine health data: appropriate wording for participant-facing materials of randomised clinical trials (CrossWord)
同意访问和使用常规健康数据:面向参与者的随机临床试验材料的适当措辞(CrossWord)
  • 批准号:
    2869207
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Studentship
MICA: Meeting global need to improve newborn care through real-world-health-data-facilitated, digital-technology-supported randomised clinical trials
MICA:通过真实世界健康数据促进、数字技术支持的随机临床试验满足全球改善新生儿护理的需求
  • 批准号:
    MR/X009831/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Research Grant
Phase 1 Randomised Clinical Trial of the First-in-Class KMO inhibitor KNS366
首创KMO抑制剂KNS366的1期随机临床试验
  • 批准号:
    10017279
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Collaborative R&D
Steroid-Reducing Options for ReLapsING PMR (STERLING-PMR): a pragmatic, randomised trial to compare the clinical and cost-effectiveness of adding immunosuppression to steroid-tapering treatment for patients with relapsing PMR, versus steroid-tapering
ReLapsING PMR 的类固醇减少方案 (STERLING-PMR):一项务实的随机试验,旨在比较在复发性 PMR 患者的类固醇逐渐减少治疗中添加免疫抑制与类固醇逐渐减少的临床和成本效益
  • 批准号:
    nhmrc : 2006408
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
    International Collaborations
Precision medicine in diabetes: Pharmacogenetic studies of large randomised controlled trials of diabetes therapies. (MRC PA: Ewan Pearson)
糖尿病精准医学:糖尿病治疗大型随机对照试验的药物遗传学研究。
  • 批准号:
    410941
  • 财政年份:
    2019
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Operating Grants
A phase III multicentre blinded randomised controlled clinical non-inferiority trial of cryopreserved platelets vs. conventional liquid-stored platelets for the management of post-surgical bleeding.
一项关于冷冻保存血小板与传统液体储存血小板治疗术后出血的 III 期多中心盲法随机对照临床非劣效性试验。
  • 批准号:
    nhmrc : GNT1156641
  • 财政年份:
    2019
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Project Grants
PET++: Improving Localisation, Diagnosis and Quantification in Clinical and Medical PET Imaging with Randomised Optimisation
PET:通过随机优化改善临床和医学 PET 成像的定位、诊断和量化
  • 批准号:
    EP/S026045/1
  • 财政年份:
    2019
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Research Grant
MICA: Phase IIb randomised clinical trial repurposing ATRA as a stromal targeting agent in a novel drug combination for pancreatic cancer (STAR-PAC2).
MICA:IIb 期随机临床试验,将 ATRA 重新用作胰腺癌新型药物组合 (STAR-PAC2) 中的基质靶向剂。
  • 批准号:
    MR/S036601/1
  • 财政年份:
    2019
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Research Grant
Strengthening exercise or combined strengthening and aerobic exercise for hip osteoarthritis: a randomised clinical trial
强化运动或结合强化运动和有氧运动治疗髋骨关节炎:一项随机临床试验
  • 批准号:
    nhmrc : GNT1159045
  • 财政年份:
    2019
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了